These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 19936977)
21. Genetic variation of the 5-HT2A receptor and response to clozapine. Burnet PW; Harrison PJ Lancet; 1995 Sep; 346(8979):909. PubMed ID: 7564705 [No Abstract] [Full Text] [Related]
22. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach. Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512 [TBL] [Abstract][Full Text] [Related]
23. Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. Reynolds GP; Zhang Z; Zhang X Am J Psychiatry; 2003 Apr; 160(4):677-9. PubMed ID: 12668355 [TBL] [Abstract][Full Text] [Related]
24. Mitchell B. Balter Award. Human leukocyte antigen-A1 predicts a good therapeutic response to clozapine with a low risk of agranulocytosis in patients with schizophrenia. Lahdelma L; Ahokas A; Andersson LC; Suvisaari J; Hovatta I; Huttunen MO; Koskimies S J Clin Psychopharmacol; 2001 Feb; 21(1):4-7. PubMed ID: 11199946 [TBL] [Abstract][Full Text] [Related]
25. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. Barlas IO; Cetin M; Erdal ME; Semiz UB; Basoglu C; Ay ME; Herken H; Uzun O Am J Med Genet B Neuropsychiatr Genet; 2009 Jan; 150B(1):56-60. PubMed ID: 18449897 [TBL] [Abstract][Full Text] [Related]
26. An emerging role for Wnt and GSK3 signaling pathways in schizophrenia. Singh KK Clin Genet; 2013 Jun; 83(6):511-7. PubMed ID: 23379509 [TBL] [Abstract][Full Text] [Related]
27. Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response. Arranz MJ; Li T; Munro J; Liu X; Murray R; Collier DA; Kerwin RW Pharmacogenetics; 1998 Dec; 8(6):481-4. PubMed ID: 9918131 [TBL] [Abstract][Full Text] [Related]
28. Association between clozapine response and allelic variation in the 5-HT2C receptor gene. Sodhi MS; Arranz MJ; Curtis D; Ball DM; Sham P; Roberts GW; Price J; Collier DA; Kerwin RW Neuroreport; 1995 Dec; 7(1):169-72. PubMed ID: 8742444 [TBL] [Abstract][Full Text] [Related]
29. Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response. Tsai SJ; Hong CJ; Yu YW; Lin CH; Song HL; Lai HC; Yang KH Schizophr Res; 2000 Sep; 44(3):177-81. PubMed ID: 10962219 [TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetics in schizophrenia: a review of clozapine studies. Kohlrausch FB Braz J Psychiatry; 2013; 35(3):305-17. PubMed ID: 24142094 [TBL] [Abstract][Full Text] [Related]
33. Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia. Xu M; Xing Q; Li S; Zheng Y; Wu S; Gao R; Yu L; Guo T; Yang Y; Liu J; Zhang A; Zhao X; He G; Zhou J; Wang L; Xuan J; Du J; Li X; Feng G; Lin Z; Xu Y; St Clair D; Lin Z; He L Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1026-32. PubMed ID: 20580759 [TBL] [Abstract][Full Text] [Related]
34. Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine. Zhao AL; Zhao JP; Zhang YH; Xue ZM; Chen JD; Chen XG Int J Neurosci; 2005 Nov; 115(11):1539-47. PubMed ID: 16223700 [TBL] [Abstract][Full Text] [Related]